|Articles|October 19, 2009

Emerging Pharma Leadership Awards - Elizabeth Mutisya
Elizabeth Mutisya, VP, US Medical Affairs, CMO, Solvay Pharmaceuticals
Download Adobe Flash Player

“We need to do a better job of delineating the value our industry provides in addressing medical problems. Health economics allows us to better quantify the benefits of our solutions to patient outcomes, health-related quality of life, and individuals involved in patient care.” Listen to the Podcast for more coverage.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Related Content